Marc Rapaport is listed as a director on 4 SEC Form D filings by 1 issuer between Jun 2020 and Aug 2025: Bryn Pharma, Inc. (Lebanon, NJ — other health care — 2020–2025; $43.5M reported sold to 246 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Lisa Licht (4 shared filings), Michelle Lobel (4 shared filings), Steven Hartman (4 shared filings), ANNE C. WHITAKER (3 shared filings), David Dworaczyk (3 shared filings) and 14 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Marc. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Marc Rapaport and found 8 differences, 1 worth asking the sponsor about: Form D filed 126 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.